Overview

A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease

Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the relationship between depressive symptoms and markers of inflammation, two predictors of heart disease.
Phase:
Phase 1
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Treatments:
Sertraline
Simvastatin